1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Kendrion N.V.
  6. News
  7. Summary
    KENDR   NL0000852531


Real-time Euronext Amsterdam  -  05/24 11:35:03 am EDT
16.80 EUR   -0.12%
05/03Kendrion N.V. Reports Earnings Results for the First Quarter Ended March 31, 2022
05/03TRANSCRIPT : Kendrion N.V., Q1 2022 Earnings Call, May 03, 2022
05/03KENDRION N.V. : 1st quarter results
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Safe, precise and reliable: Brakes for medical robots from Kendrion

01/14/2022 EDT
January 14, 2022
Safe, precise and reliable: Brakes for medical robots from Kendrion
Surgical robots allow surgeons to perform movements with particular precision - for the benefit of the patient. Therefore, it is no surprise that this special cooperation between humans and machines is gaining ground in the medical field. A particularly important component in the drives of the robots are the brakes, which must function with the utmost precision and absolute reliability in this application. Solutions by Kendrion meet these requirements in every aspect.

"Our brakes are highly demanded by manufacturers of medical robots," says Daniel Guggolz, Global Sales Manager at Kendrion. "We have a great level of application expertise in this area and can also flexibly fulfill individual requests." For an assured high quality standard, the brakes are thoroughly tested before delivery. In addition, we meet the specific requirements regarding documentation and compliance with processes that are essential in medical technology.

The application examples from this industry are numerous: For example, our permanent magnet brakes are used in surgical robots for orthopedic applications, among others. "Safety, reliability and precision are the distinctive requirements placed on electromagnetic brake solutions in medical technology," emphasizes Daniel Guggolz. "Precise positioning of medical devices, reliable holding in a specific position, as well as low-noise operation and a high power density are top priorities, ensuring the safety of the patient at all times." No problem with permanent magnet brakes from Kendrion: they feature safe, residual torque-free release in any installation position and backlash-free transmission of the braking torque. At the same time, they offer further advantages, such as above-average consistency of the holding torque and the dynamic braking torque over the entire service life. The brakes also have an impressively long service life and are wear-resistant.

Kendrion developed a customer-specific emergency stop brake for a start-up that launched an innovative solution for robot-assisted surgery. "The customer's requirements included a compact design and a large inner diameter," describes Daniel Guggolz. "In addition, the brake should consume as little energy as possible to keep heat generation low." Kendrion designed a suitable solution based on the Servo Slim Line series. They are characterized by their compact design and high power density. The power consumption was modified so that the brake operates reliably and heat generation is minimal.

The examples show: Having Kendrion as a partner allows medical device manufacturers to save costs and develop innovative technologies that support people's health and quality of life. "In the case of medical robots, it is impressively demonstrated how intelligent technology can support surgical success," Daniel Guggolz concludes. "Kendrion contributes to the development of this industry with its safe and high-quality brakes. With our broad product portfolio, we find the right solution for all project-specific requirements - for both established and start-up companies."


Kendrion NV published this content on 14 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 January 2022 07:54:04 UTC.

© Publicnow 2022
All news about KENDRION N.V.
05/03Kendrion N.V. Reports Earnings Results for the First Quarter Ended March 31, 2022
05/03TRANSCRIPT : Kendrion N.V., Q1 2022 Earnings Call, May 03, 2022
05/03KENDRION N.V. : 1st quarter results
04/13KENDRION N.V. : Ex-dividend day for final dividend (optional)
04/12KENDRION N : Remuneration Policy Executive Board
04/12KENDRION N : Presentation AGM
04/12KENDRION N : Presentation Deloitte
04/12KENDRION N : Kendrion AGM confirms all proposals and announces refinancing
04/11KENDRION N : AGM confirms all proposals and announces refinancing
03/30KENDRION N : offers holistic solutions in the field of control technology for AGVs
More news
Sales 2022 493 M 527 M 527 M
Net income 2022 20,4 M 21,8 M 21,8 M
Net Debt 2022 127 M 135 M 135 M
P/E ratio 2022 12,5x
Yield 2022 4,22%
Capitalization 251 M 269 M 268 M
EV / Sales 2022 0,77x
EV / Sales 2023 0,70x
Nbr of Employees 2 716
Free-Float 94,3%
Duration : Period :
Kendrion N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KENDRION N.V.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 16,82 €
Average target price 23,13 €
Spread / Average Target 37,5%
EPS Revisions
Managers and Directors
Joep A. J. van Beurden Chief Executive Officer
Jeroen Hemmen Chief Financial Officer
Frits J. van Hout Chairman-Supervisory Board
Marion J. G. Mestrom Independent Member-Supervisory Board
Jabine T. M. van der Meijs Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
KENDRION N.V.-20.10%268
APTIV PLC-43.01%25 468
WEICHAI POWER CO., LTD.-25.95%14 732
HYUNDAI MOBIS CO.,LTD-20.24%14 670